The 20th annual edition of the National Comprehensive Cancer Network (NCCN) clinical practice guidelines for prostate cancer has been published. The new guidelines include major changes on use of imaging, including the use of multiparametric MRI for the risk stratification of men on active surveillance and use of PET for bone scans. New guidance on molecular testing and the systemic treatment of castration-resistant prostate cancer are also included.